More than 700 items collected at San Diego County Fair lost and found
Published Tue, 04 Mar 2025 11:56:08 GMT
Decision to join Toronto a ‘no-brainer’ for newest Maple Leaf Max Domi
Published Tue, 04 Mar 2025 11:56:08 GMT
Canadians to receive one-time grocery rebate this week. How much and when?
Published Tue, 04 Mar 2025 11:56:08 GMT
Alberta weekend tornado that damaged, destroyed homes rated rare, violent twister
Published Tue, 04 Mar 2025 11:56:08 GMT
UK mortgage rates spike to highest level since Truss tax plan spooked markets
Published Tue, 04 Mar 2025 11:56:08 GMT
Alcaraz starts his Wimbledon with a straight-set win and defending champion Rybakina beats Rogers
Published Tue, 04 Mar 2025 11:56:08 GMT
Suspicious powder found at the White House when Biden was gone was cocaine, AP sources say
Published Tue, 04 Mar 2025 11:56:08 GMT
Wekweeti, N.W.T., residents return home as wildfire under control
Published Tue, 04 Mar 2025 11:56:08 GMT
6 South African opposition parties to discuss forming alliance to challenge long-ruling ANC
Published Tue, 04 Mar 2025 11:56:08 GMT
Miki Sudo successfully defends hot dog-eating title; stormy weather delays men’s contest
Published Tue, 04 Mar 2025 11:56:08 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says